Showing 1 - 1 results of 1 for search '"R/R DLBCL"', query time: 0.02s Refine Results
  1. 1
    Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma

    Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma by Narendranath Epperla, Loretta J. Nastoupil, Bruce Feinberg, John Galvin, Prathamesh Pathak, Theresa Amoloja, Danielle Gentile, Kim Saverno

    Published 2025-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: